Firm News: Apr. 2015

$2.4 Billion Settlement Reached in Actos Products Liability Litigation

Attorney Richard J. Arsenault of Neblett, Beard & Arsenault, and Paul J. Pennock of Weitz & Luxenberg, were the court-appointed co-lead Plaintiffs’ counsel in the Multi-District Litigation (MDL 2299) pending in Lafayette, Louisiana.  This settlement relates to legal actions filed beginning in 2011 in response to Plaintiffs diagnosed with bladder cancer as a result of…

W&L’s Bilsborrow Will Attend AAJ Leadership Academy

Attorney James Bilsborrow is one of a dozen lawyers from around the nation chosen to participate this year in an American Association for Justice (AAJ) training academy to develop promising new leaders of the legal profession. Bilsborrow will attend the AAJ’s Leadership Academy between May and October — at sessions first in Dallas, then in Montreal, and…

W&L Accepting Zimmer Persona Knee Replacement Cases

A recent voluntary recall of the porous coated, uncemented Zimmer Persona Knee Trabecular Metal Tibial Plates, which the U.S. Food and Drug Administration (FDA) subsequently categorized as a Class II recall, has led Weitz & Luxenberg, P.C., to begin accepting cases involving Zimmer Persona Knee replacement injuries, the law firm today announced. The company that…

W&L Accepting Zofran Birth Defect Claims

W&L is now accepting cases of congenital heart defects and cleft facial abnormalities in children whose mothers during pregnancy took the prescription drug Zofran to relieve the symptoms of morning sickness. Zofran — generic name ondansetron — has never been approved by the U.S. Food & Drug Administration (FDA) for treatment of morning sickness symptoms. Further, medical studies…

Get the Help You Need Today

Free Case Review